Cargando…
Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio
SIMPLE SUMMARY: Hypothyroidism is a common toxicity experienced after radiotherapy for head and neck malignancies. In this systemic review of the literature, we consolidated the body of existing evidence regarding the incidence and risk factors for radiotherapy-induced hypothyroidism. We found large...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486996/ https://www.ncbi.nlm.nih.gov/pubmed/37686597 http://dx.doi.org/10.3390/cancers15174321 |
_version_ | 1785103130031030272 |
---|---|
author | Rooney, Michael K. Andring, Lauren M. Corrigan, Kelsey L. Bernard, Vincent Williamson, Tyler D. Fuller, Clifton D. Garden, Adam S. Gunn, Brandon Lee, Anna Moreno, Amy C. Morrison, William H. Phan, Jack Rosenthal, David I. Spiotto, Michael Frank, Steven J. |
author_facet | Rooney, Michael K. Andring, Lauren M. Corrigan, Kelsey L. Bernard, Vincent Williamson, Tyler D. Fuller, Clifton D. Garden, Adam S. Gunn, Brandon Lee, Anna Moreno, Amy C. Morrison, William H. Phan, Jack Rosenthal, David I. Spiotto, Michael Frank, Steven J. |
author_sort | Rooney, Michael K. |
collection | PubMed |
description | SIMPLE SUMMARY: Hypothyroidism is a common toxicity experienced after radiotherapy for head and neck malignancies. In this systemic review of the literature, we consolidated the body of existing evidence regarding the incidence and risk factors for radiotherapy-induced hypothyroidism. We found large variations in estimates, although the most recent large investigations suggest an overall incidence of approximately 40–50%, which is significantly higher than many historical estimates. Furthermore, we synthesized the evidence regarding the dosimetric-based prediction of hypothyroidism, including a summary of various proposed dosimetric parameters that may be utilized clinically to optimize plans. We found a paucity of literature investigating the use of modern advanced radiotherapy techniques, such as particle therapy or MRI-guided radiotherapy, to reduce the risk of thyroid toxicity. These findings may be useful to guide clinicians and researchers aiming to improve the care of patients undergoing radiotherapy for head and neck cancer. ABSTRACT: (1) Background: Radiotherapy (RT) is a central component for the treatment of many head and neck cancers. In this systematic review of the literature, we aimed to characterize and quantify the published evidence on RT-related hypothyroidism, including estimated incidence, clinical risk factors, and dosimetric parameters that may be used to guide clinical decision making. Furthermore, we aimed to identify potential areas of improvement in the prevention and clinical management of RT-induced hypothyroidism, including the role of modern advanced therapeutic techniques. (2) Methods: We conducted a systemic review of the literature in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. PubMed and Google Scholar were searched to identify original research articles describing the incidence, mechanism, dosimetry, treatment, or prevention of radiation-related hypothyroidism for adults receiving RT for the treatment of head and neck cancers. The snowball method was used to identify additional articles. For identified articles, we tabulated several datapoints, including publication date, patient sample size, estimated hypothyroidism incidence, cancer site/type, follow-up period, radiation modality and technique, use of multimodality therapy, method of thyroid function evaluation, and proposed dosimetric predictors of hypothyroidism. (3) Results: One hundred and eleven articles met inclusion criteria, reflecting a range of head and neck cancer subtypes. There was a large variation in the estimated incidence of RT-related hypothyroidism, with a median estimate of 36% (range 3% to 79%). Reported incidence increased in later publication dates, which was likely related to improved screening and longer follow up. There were a wide variety of predictive metrics used to identify patients at high risk of hypothyroidism, the most common of which were volumetric and mean dosimetrics related to the thyroid gland (Vxx%, Dmean). More recently, there has been increasing evidence to suggest that the thyroid gland volume itself and the volume of the thyroid gland spared from high-dose radiation (VSxx) may better predict thyroid function after RT. There were no identified studies investigating the role of advanced radiotherapeutic techniques such as MRI-guided RT or particle therapy to decrease RT-related hypothyroidism. Conclusions: Hypothyroidism is a common toxicity resulting from therapeutic radiation for head and neck cancer with recent estimates suggesting 40–50% of patients may experience hypothyroidism after treatment. Dosimetric predictive models are increasingly able to accurately identify patients at risk of hypothyroidism, especially those utilizing thyroid VS metrics. Further investigation regarding the potential for advanced radiotherapeutic therapies to decrease RT-induced thyroid dysfunction is needed. |
format | Online Article Text |
id | pubmed-10486996 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104869962023-09-09 Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio Rooney, Michael K. Andring, Lauren M. Corrigan, Kelsey L. Bernard, Vincent Williamson, Tyler D. Fuller, Clifton D. Garden, Adam S. Gunn, Brandon Lee, Anna Moreno, Amy C. Morrison, William H. Phan, Jack Rosenthal, David I. Spiotto, Michael Frank, Steven J. Cancers (Basel) Systematic Review SIMPLE SUMMARY: Hypothyroidism is a common toxicity experienced after radiotherapy for head and neck malignancies. In this systemic review of the literature, we consolidated the body of existing evidence regarding the incidence and risk factors for radiotherapy-induced hypothyroidism. We found large variations in estimates, although the most recent large investigations suggest an overall incidence of approximately 40–50%, which is significantly higher than many historical estimates. Furthermore, we synthesized the evidence regarding the dosimetric-based prediction of hypothyroidism, including a summary of various proposed dosimetric parameters that may be utilized clinically to optimize plans. We found a paucity of literature investigating the use of modern advanced radiotherapy techniques, such as particle therapy or MRI-guided radiotherapy, to reduce the risk of thyroid toxicity. These findings may be useful to guide clinicians and researchers aiming to improve the care of patients undergoing radiotherapy for head and neck cancer. ABSTRACT: (1) Background: Radiotherapy (RT) is a central component for the treatment of many head and neck cancers. In this systematic review of the literature, we aimed to characterize and quantify the published evidence on RT-related hypothyroidism, including estimated incidence, clinical risk factors, and dosimetric parameters that may be used to guide clinical decision making. Furthermore, we aimed to identify potential areas of improvement in the prevention and clinical management of RT-induced hypothyroidism, including the role of modern advanced therapeutic techniques. (2) Methods: We conducted a systemic review of the literature in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. PubMed and Google Scholar were searched to identify original research articles describing the incidence, mechanism, dosimetry, treatment, or prevention of radiation-related hypothyroidism for adults receiving RT for the treatment of head and neck cancers. The snowball method was used to identify additional articles. For identified articles, we tabulated several datapoints, including publication date, patient sample size, estimated hypothyroidism incidence, cancer site/type, follow-up period, radiation modality and technique, use of multimodality therapy, method of thyroid function evaluation, and proposed dosimetric predictors of hypothyroidism. (3) Results: One hundred and eleven articles met inclusion criteria, reflecting a range of head and neck cancer subtypes. There was a large variation in the estimated incidence of RT-related hypothyroidism, with a median estimate of 36% (range 3% to 79%). Reported incidence increased in later publication dates, which was likely related to improved screening and longer follow up. There were a wide variety of predictive metrics used to identify patients at high risk of hypothyroidism, the most common of which were volumetric and mean dosimetrics related to the thyroid gland (Vxx%, Dmean). More recently, there has been increasing evidence to suggest that the thyroid gland volume itself and the volume of the thyroid gland spared from high-dose radiation (VSxx) may better predict thyroid function after RT. There were no identified studies investigating the role of advanced radiotherapeutic techniques such as MRI-guided RT or particle therapy to decrease RT-related hypothyroidism. Conclusions: Hypothyroidism is a common toxicity resulting from therapeutic radiation for head and neck cancer with recent estimates suggesting 40–50% of patients may experience hypothyroidism after treatment. Dosimetric predictive models are increasingly able to accurately identify patients at risk of hypothyroidism, especially those utilizing thyroid VS metrics. Further investigation regarding the potential for advanced radiotherapeutic therapies to decrease RT-induced thyroid dysfunction is needed. MDPI 2023-08-29 /pmc/articles/PMC10486996/ /pubmed/37686597 http://dx.doi.org/10.3390/cancers15174321 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Systematic Review Rooney, Michael K. Andring, Lauren M. Corrigan, Kelsey L. Bernard, Vincent Williamson, Tyler D. Fuller, Clifton D. Garden, Adam S. Gunn, Brandon Lee, Anna Moreno, Amy C. Morrison, William H. Phan, Jack Rosenthal, David I. Spiotto, Michael Frank, Steven J. Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio |
title | Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio |
title_full | Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio |
title_fullStr | Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio |
title_full_unstemmed | Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio |
title_short | Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio |
title_sort | hypothyroidism following radiotherapy for head and neck cancer: a systematic review of the literature and opportunities to improve the therapeutic ratio |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486996/ https://www.ncbi.nlm.nih.gov/pubmed/37686597 http://dx.doi.org/10.3390/cancers15174321 |
work_keys_str_mv | AT rooneymichaelk hypothyroidismfollowingradiotherapyforheadandneckcancerasystematicreviewoftheliteratureandopportunitiestoimprovethetherapeuticratio AT andringlaurenm hypothyroidismfollowingradiotherapyforheadandneckcancerasystematicreviewoftheliteratureandopportunitiestoimprovethetherapeuticratio AT corrigankelseyl hypothyroidismfollowingradiotherapyforheadandneckcancerasystematicreviewoftheliteratureandopportunitiestoimprovethetherapeuticratio AT bernardvincent hypothyroidismfollowingradiotherapyforheadandneckcancerasystematicreviewoftheliteratureandopportunitiestoimprovethetherapeuticratio AT williamsontylerd hypothyroidismfollowingradiotherapyforheadandneckcancerasystematicreviewoftheliteratureandopportunitiestoimprovethetherapeuticratio AT fullercliftond hypothyroidismfollowingradiotherapyforheadandneckcancerasystematicreviewoftheliteratureandopportunitiestoimprovethetherapeuticratio AT gardenadams hypothyroidismfollowingradiotherapyforheadandneckcancerasystematicreviewoftheliteratureandopportunitiestoimprovethetherapeuticratio AT gunnbrandon hypothyroidismfollowingradiotherapyforheadandneckcancerasystematicreviewoftheliteratureandopportunitiestoimprovethetherapeuticratio AT leeanna hypothyroidismfollowingradiotherapyforheadandneckcancerasystematicreviewoftheliteratureandopportunitiestoimprovethetherapeuticratio AT morenoamyc hypothyroidismfollowingradiotherapyforheadandneckcancerasystematicreviewoftheliteratureandopportunitiestoimprovethetherapeuticratio AT morrisonwilliamh hypothyroidismfollowingradiotherapyforheadandneckcancerasystematicreviewoftheliteratureandopportunitiestoimprovethetherapeuticratio AT phanjack hypothyroidismfollowingradiotherapyforheadandneckcancerasystematicreviewoftheliteratureandopportunitiestoimprovethetherapeuticratio AT rosenthaldavidi hypothyroidismfollowingradiotherapyforheadandneckcancerasystematicreviewoftheliteratureandopportunitiestoimprovethetherapeuticratio AT spiottomichael hypothyroidismfollowingradiotherapyforheadandneckcancerasystematicreviewoftheliteratureandopportunitiestoimprovethetherapeuticratio AT frankstevenj hypothyroidismfollowingradiotherapyforheadandneckcancerasystematicreviewoftheliteratureandopportunitiestoimprovethetherapeuticratio |